Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Gender differences in psychotropic drug metabolism.

Literature DB >> 9230636

Gender differences in psychotropic drug metabolism.

B G Pollock¹.

Abstract

Mesh：

Substances：

Year: 1997 PMID： 9230636

Source DB: PubMed Journal: Psychopharmacol Bull ISSN： 0048-5764

Keyword Cloud
Cited

× No keyword cloud information.

14 in total

1. Are commonly used psychoactive medications associated with lower urinary tract symptoms?

Authors: Susan A Hall; Nancy N Maserejian; Carol L Link; William D Steers; John B McKinlay
Journal: Eur J Clin Pharmacol Date: 2011-12-04 Impact factor: 2.953

Review 2. Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance.

Authors: Eveline Jaquenoud Sirot; Jan Willem van der Velden; Katharina Rentsch; Chin B Eap; Pierre Baumann
Journal: Drug Saf Date: 2006 Impact factor: 5.606

Review 3. [Differences between men and women in side effects of second-generation antipsychotics].

Authors: W Aichhorn; A B Whitworth; E M Weiss; H Hinterhuber; J Marksteiner
Journal: Nervenarzt Date: 2007-01 Impact factor: 1.214

Review 4. New atypical antipsychotics. Experience and utility in the elderly.

Authors: R A Sweet; B G Pollock
Journal: Drugs Aging Date: 1998-02 Impact factor: 3.923

Review 5. Second-generation antipsychotics: is there evidence for sex differences in pharmacokinetic and adverse effect profiles?

Authors: Wolfgang Aichhorn; Alexandra B Whitworth; Elisabeth M Weiss; Josef Marksteiner
Journal: Drug Saf Date: 2006 Impact factor: 5.606

Gender differences in psychotropic drug metabolism.

1. Are commonly used psychoactive medications associated with lower urinary tract symptoms?

Review 2. Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance.

Review 3. [Differences between men and women in side effects of second-generation antipsychotics].

Review 4. New atypical antipsychotics. Experience and utility in the elderly.

Review 5. Second-generation antipsychotics: is there evidence for sex differences in pharmacokinetic and adverse effect profiles?

Review 6. Human pharmacogenomic variations and their implications for antifungal efficacy.

Review 7. How important are gender differences in pharmacokinetics?

Review 8. The selective serotonin reuptake inhibitor sertraline: its profile and use in psychiatric disorders.

Review 9. Metabolism of tricyclic antidepressants.

10. Gender difference in ifosfamide metabolism by human liver microsomes.